ギテルマン症候群
WordNet
- a pattern of symptoms indicative of some disease
- a complex of concurrent things; "every word has a syndrome of meanings"
PrepTutorEJDIC
- (疾患の徴候となる一群の)症徴候,症候群 / (事件・社会的状態などのパターンを示す)徴候形態
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/05/29 16:00:15」(JST)
[Wiki en表示]
Gitelman syndrome |
Classification and external resources |
ICD-10 |
N25.8 + E87.6 + E83.4 |
OMIM |
263800 |
DiseasesDB |
31860 |
eMedicine |
article/238670 |
MeSH |
D053579 |
Gitelman syndrome is an autosomal recessive kidney disorder characterized by hypokalemic metabolic alkalosis with hypocalciuria, and hypomagnesemia. It is caused by loss of function mutations of the thiazide sensitive sodium-chloride symporter (also known as NCC, NCCT, or TSC) located in the distal convoluted tubule.[1]
Gitelman syndrome was formerly considered a subset of Bartter syndrome until the distinct genetic and molecular bases of these disorders were identified. Bartter syndrome is also an autosomal recessive hypokalemic metabolic alkalosis, but it derives from a mutation to the NKCC2 found in the thick ascending limb of the loop of Henle.[2]
Contents
- 1 Cause
- 2 Presentation
- 3 Eponym
- 4 References
- 5 External links
Cause
A model of transport mechanisms in the distal convoluted tubule. Sodium-chloride (NaCl) enters the cell via the apical thiazide-sensitive NCC and leaves the cell through the basolateral Cl
− channel (ClC-Kb), and the Na+/K+-ATPase. Indicated also are the recently identified magnesium channel TRPM6 in the apical membrane, and a putative Na/Mg exchanger in the basolateral membrane. These transport mechanisms play a role in familial hypokalemia-hypomagnesemia or Gitelman's syndrome.
Gitelman syndrome has an autosomal recessive pattern of inheritance.
Gitelman's syndrome is linked to inactivating mutations in the SLC12A3 gene resulting in a loss of function of the encoded thiazide-sensitive sodium-chloride co-transporter (NCCT). This cell membrane protein participates in the control of ion homeostasis at the distal convoluted tubule portion of the nephron.
Gitelman's syndrome is an autosomal-recessive disorder: one defective allele has to be inherited from each parent.
Presentation
People suffering from Gitelman's syndrome present symptoms which are identical to those of patients who are on thiazide diuretics[3]
Clinical symptoms for this disease are hypochloremic metabolic alkalosis, hypokalemia, and hypocalciuria. Hypomagnesemia is present in many but not all cases. In contrast to patients with Gordon's syndrome, those suffering from Gitelman's syndrome are generally normotensive. Carriers of Gitelman's syndrome-linked mutations are often asymptomatic while some complain of mild muscular cramps or weakness expressed as fatigue or irritability. More severe symptoms such as tetany and paralysis have however also been reported. Phenotypic variations observed among patients probably result from differences in their genetic background and may depend on which particular amino acid in the NCCT protein has been mutated.
See Naesens et al. for a recent review.[4]
Eponym
It is named for Hillel J. Gitelman (1932–2015), an American physician.[5][6][7]
References
- ^ Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitleman HJ, Lifton RP (Jan 1996). "Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter.". Nat. Genet. 12 (1): 24–30. doi:10.1038/ng0196-24. PMID 8528245.
- ^ Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP (June 1996). "Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2". Nat. Genet. 13 (2): 183–8. doi:10.1038/ng0696-183. PMID 8640224.
- ^ O'Shaughnessy KM, Karet FE (2004). "Salt handling and hypertension". J. Clin. Invest. 113 (8): 1075–81. doi:10.1172/JCI200421560. PMC 385413. PMID 15085183.
- ^ Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D (2004). "Bartter's and Gitelman's syndromes: from gene to clinic". Nephron. Physiology 96 (3): p65–78. doi:10.1159/000076752. PMID 15056980.
- ^ synd/2329 at Who Named It?
- ^ Gitelman HJ, Graham JB, Welt LG (1966). "A new familial disorder characterized by hypokalemia and hypomagnesemia". Trans. Assoc. Am. Physicians 79: 221–35. PMID 5929460.
- ^ Unwin RJ, Capasso G (2006). "Bartter's and Gitelman's syndromes: their relationship to the actions of loop and thiazide diuretics" (PDF). CURRENT OPINION IN PHARMACOLOGY 6 (2): 208–213. doi:10.1016/j.coph.2006.01.002. PMID 16490401.
External links
- Urinary system
- Pathology
- Urologic disease / Uropathy (N00–N39, 580–599)
|
|
Abdominal |
Nephropathy/
(nephritis+
nephrosis) |
Glomerulopathy/
glomerulitis/
(glomerulonephritis+
glomerulonephrosis) |
Primarily
nephrotic |
Non-proliferative |
- Minimal change
- Focal segmental
- Membranous
|
|
Proliferative |
- Mesangial proliferative
- Endocapillary proliferative
- Membranoproliferative/mesangiocapillary
|
|
By condition |
|
|
|
Primarily
nephritic,
RPG |
Type I RPG/Type II hypersensitivity |
|
|
Type II RPG/Type III hypersensitivity |
- Post-streptococcal
- Lupus
- IgA/Berger's
|
|
Type III RPG/Pauci-immune |
- Granulomatosis with polyangiitis
- Microscopic polyangiitis
- Churg–Strauss syndrome
|
|
|
|
Tubulopathy/
tubulitis |
Proximal |
|
|
Thick ascending |
|
|
Distal convoluted |
|
|
Collecting duct |
- Liddle's syndrome
- RTA
- Diabetes insipidus
|
|
Renal papilla |
|
|
Major calyx/pelvis |
- Hydronephrosis
- Pyonephrosis
- Reflux nephropathy
|
|
Any/all |
|
|
|
Interstitium |
- Interstitial nephritis
- Pyelonephritis
- Danubian endemic familial nephropathy
|
|
Any/all |
General syndromes |
- Renal failure
- Acute renal failure
- Chronic kidney disease
- Uremic pericarditis
- Uremia
|
|
Vascular |
- Renal artery stenosis
- Renal ischemia
- Hypertensive nephropathy
- Renovascular hypertension
- Renal cortical necrosis
|
|
Other |
- Analgesic nephropathy
- Renal osteodystrophy
- Nephroptosis
- Abderhalden–Kaufmann–Lignac syndrome
|
|
|
|
Ureter |
- Ureteritis
- Ureterocele
- Megaureter
|
|
|
Pelvic |
Bladder |
- Cystitis
- Interstitial cystitis
- Hunner's ulcer
- Trigonitis
- Hemorrhagic cystitis
- Neurogenic bladder dysfunction
- Bladder sphincter dyssynergia
- Vesicointestinal fistula
- Vesicoureteral reflux
|
|
Urethra |
- Urethritis
- Non-gonococcal urethritis
- Urethral syndrome
- Urethral stricture/Meatal stenosis
- Urethral caruncle
|
|
|
Any/all |
- Obstructive uropathy
- Urinary tract infection
- Retroperitoneal fibrosis
- Urolithiasis
- Bladder stone
- Kidney stone
- Renal colic
- Malakoplakia
- Urinary incontinence
|
|
Index of the urinary system
|
|
Description |
- Anatomy
- Physiology
- Development
- Cells
|
|
Disease |
- Electrolyte and acid-base
- Congenital
- Neoplasms and cancer
- Other
- Symptoms and signs
- Urine tests
- Blood tests
|
|
Treatment |
- Procedures
- Drugs
- Intravenous fluids
|
|
|
Genetic disorder, membrane: Solute carrier disorders
|
|
1-10 |
- SLC1A3
- SLC2A1
- SLC2A5
- SLC2A10
- Arterial tortuosity syndrome
- SLC3A1
- SLC4A1
- Hereditary spherocytosis 4/Hereditary elliptocytosis 4
- SLC4A11
- Congenital endothelial dystrophy type 2
- Fuchs' dystrophy 4
- SLC5A1
- Glucose-galactose malabsorption
- SLC5A2
- SLC5A5
- Thyroid dyshormonogenesis type 1
- SLC6A19
- SLC7A7
- Lysinuric protein intolerance
- SLC7A9
|
|
11-20 |
- SLC11A1
- SLC12A3
- SLC16A1
- SLC16A2
- Allan–Herndon–Dudley syndrome
- SLC17A5
- SLC17A8
|
|
21-40 |
- SLC26A2
- Multiple epiphyseal dysplasia 4
- Achondrogenesis type 1B
- Recessive multiple epiphyseal dysplasia
- Atelosteogenesis, type II
- Diastrophic dysplasia
- SLC26A4
- SLC35C1
- SLC39A4
- Acrodermatitis enteropathica
- SLC40A1
|
|
see also solute carrier family
Index of cells
|
|
Description |
- Structure
- Organelles
- peroxisome
- cytoskeleton
- centrosome
- epithelia
- cilia
- mitochondria
- Membranes
- Membrane transport
- ion channels
- vesicular transport
- solute carrier
- ABC transporters
- ATPase
- oxidoreduction-driven
|
|
Disease |
- Structural
- peroxisome
- cytoskeleton
- cilia
- mitochondria
- nucleus
- scleroprotein
- Membrane
- channelopathy
- solute carrier
- ATPase
- ABC transporters
- other
- extracellular ligands
- cell surface receptors
- intracellular signalling
- Vesicular transport
- Pore-forming toxins
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Quantitation of Plasma Renin Activity in Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
- Van Der Gugten JG1,2, Holmes DT3,4.
- Methods in molecular biology (Clifton, N.J.).Methods Mol Biol.2016;1378:243-53. doi: 10.1007/978-1-4939-3182-8_26.
- Accurate determination of plasma renin activity (PRA) is essential for the development and maintenance of an effective screening program for primary aldosteronism (PA). PRA measurement can also be useful in the investigation of renal artery stenosis, syndrome of mineralocorticoid excess, Addison's d
- PMID 26602136
- Renal involvement in primary Sjögren syndrome.
- François H1, Mariette X2.
- Nature reviews. Nephrology.Nat Rev Nephrol.2015 Nov 16. doi: 10.1038/nrneph.2015.174. [Epub ahead of print]
- Primary Sjögren syndrome (pSS) is an autoimmune disorder characterized by lymphoplasmacytic infiltration of the exocrine (salivary and lachrymal) glands that results in sicca symptoms (dryness of the eyes and mouth). Systemic complications can occur in pSS, but renal involvement is rare, affecting
- PMID 26568188
- Bartter/Gitelman syndromes as a model to study systemic oxidative stress in humans.
- Maiolino G1, Azzolini M1, Paolo Rossi G1, Davis PA2, Calò LA3.
- Free radical biology & medicine.Free Radic Biol Med.2015 Nov;88(Pt A):51-8. doi: 10.1016/j.freeradbiomed.2015.02.037. Epub 2015 Mar 12.
- Reactive oxygen species (ROS) are intermediates in reduction-oxidation reactions that begin with the addition of one electron to molecular oxygen, generating the primary ROS superoxide, which in turn interacts with other molecules to produce secondary ROS, such as hydrogen peroxide, hydroxyl radical
- PMID 25770663
Japanese Journal
- Bartter症候群とGitelman症候群 (特集 水電解質代謝異常と遺伝疾患)
- 症例報告 Gitelman症候群に合併した乾癬様皮疹に対してマグネシウム補充療法が著効した1例
- 臨床皮膚科 = Japanese journal of clinical dermatology 69(4), 343-347, 2015-04
- NAID 40020414349
- Bartter症候群/Gitelman症候群 (特集 遺伝性腎疾患)
- The Japanese journal of nephrology = 日本腎臓学会誌 57(4), 743-750, 2015
- NAID 40020503155
Related Links
- Consumer-friendly information about human genetics from the U.S. National Library of Medicine. ... Gitelman syndrome is a kidney disorder that causes an imbalance of charged atoms (ions) in the body, including ions of potassium ...
- Bartter syndrome and Gitelman syndrome (also called tubular hypomagnesemia-hypokalemia with hypocalciuria) areautosomal recessivedisorders with characteristic sets of metabolic abnormalities. These include hypokalemia ... ...
★リンクテーブル★
[★]
- 英
- Gitelman's syndrome、Gitelman syndrome
- 同
- Gitelman症候群
- 関
- 利尿薬。バーター症候群、Bartter症候群
概念
- チアジド系利尿薬感受性Na-Cl co transporter(NCCT)の機能変異により、ナトリウム吸収が障害される疾患である。ナトリウムと塩素イオンの喪失によるhypovolemiaによりRAA系が亢進し、高アルドステロン血症を呈するが、高血圧とはならない。アルドステロンによるカリウム排泄の亢進と、集合管でのナトリウム再吸収亢進によりカリウムイオン・水素イオン排泄亢進により低カリウム血症、代謝性アルカローシスをきたす。バーター症候群と異なり、低マグネシウム血症をきたすのが特徴的である。
バーター症候群とギテルマン症候群
- 出典不明
参考
- 1. GITELMAN SYNDROME - OMIM
- http://omim.org/entry/263800
- 2. [charged] Bartter and Gitelman syndromes - uptodate [1]
- 3. [charged] Regulation of magnesium balance - uptodate [2]
[★]